3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
26
Lymphoma, Large B-Cell, Diffuse
17
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Lymphoma
6
Neoplasms
5
Lymphoma, Non-Hodgkin
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Leukemia, Biphenotypic, Acute
3
Recurrence
2
Prostatic Neoplasms, Castration-Resistant
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Ovarian Neoplasms
2
Myasthenia Gravis
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Diseases
1
Interventions
ravulizumab
1
Prednisone
1
Prednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Adrenal Insufficiency
×
Prednisone
×
Clear all
NCT07221838
2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4
Recruiting
75 enrolled